DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo-Reference-Cited by-同舟云学术

DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo

Published:2022-05-28 Issue:26 Volume:18 Page:2108063
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Lucas Christopher R.¹,Halley Patrick D.²,Chowdury Amjad A.²,Harrington Bonnie K.³,Beaver Larry⁴,Lapalombella Rosa⁴,Johnson Amy J.⁴,Hertlein Erin K.⁴,Phelps Mitch A.⁵,Byrd John C.³,Castro Carlos E.⁶^ORCID

Affiliation:

1. Department of Mechanical and Aerospace Engineering Comprehensive Cancer Center The Ohio State University Columbus Columbus OH 43210 USA

2. Department of Mechanical and Aerospace Engineering The Ohio State University Columbus OH 43210 USA

3. Comprehensive Cancer Center College of Veterinary Medicine The Ohio State University Columbus OH 43210 USA

4. Comprehensive Cancer Center The Ohio State University Columbus OH 43210 USA

5. Division of Pharmaceutics and Pharmaceutical Chemistry College of Pharmacy The Ohio State University Columbus OH 43210 USA

6. Department of Mechanical and Aerospace Engineering Biophysics Graduate Program Department of Physics The Ohio State University Columbus OH 43210 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202108063

Reference57 articles.

1. Cancer nanomedicine: progress, challenges and opportunities

2. Cancer nanomedicine: a review of recent success in drug delivery

3. Advances and Challenges of Liposome Assisted Drug Delivery